Dataset Information


Enantioselective metabolism of quizalofop-ethyl in rat.

ABSTRACT: The pharmacokinetic and distribution of the enantiomers of quizalofop-ethyl and its metabolite quizalofop-acid were studied in Sprague-Dawley male rats. The two pairs of enantiomers were determined using a validated chiral high-performance liquid chromatography method. Animals were administered quizalofop-ethyl at 10 mg kg(-1) orally and intravenously. It was found high concentration of quizalofop-acid in the blood and tissues by both intragastric and intravenous administration, and quizalofop-ethyl could not be detected through the whole study which indicated a quick metabolism of quizalofop-ethyl to quizalofop-acid in vivo. In almost all the samples, the concentrations of (+)-quizalofop-acid exceeded those of (-)-quizalofop-acid. Quizalofop-acid could still be detected in the samples even at 120 h except in brain due to the function of blood-brain barrier. Based on a rough calculation, about 8.77% and 2.16% of quizalofop-acid were excreted through urine and feces after intragastric administration. The oral bioavailability of (+)-quizalofop-acid and (-)-quizalofop-acid were 72.8% and 83.6%.


PROVIDER: S-EPMC4071037 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-04-18 | GSE121419 | GEO
2017-01-01 | S-EPMC5424357 | BioStudies
2018-01-01 | S-EPMC6098220 | BioStudies
2018-08-08 | GSE114573 | GEO
2015-01-01 | S-EPMC4507534 | BioStudies
1996-01-01 | S-EPMC1217716 | BioStudies
2019-01-01 | S-EPMC6983174 | BioStudies
2017-01-01 | S-EPMC5545008 | BioStudies
| PRJNA497292 | ENA
2020-01-01 | S-EPMC7557254 | BioStudies